2011
DOI: 10.1007/s10014-011-0033-5
|View full text |Cite
|
Sign up to set email alerts
|

MGMT promoter methylation and temozolomide response in choroid plexus carcinoma

Abstract: Choroid plexus carcinoma (CPC) is a malignant tumor with a strong tendency to spread along the cerebrospinal fluid pathway. There is no standardized chemotherapy protocol for this rare tumor. We report a 38-year-old man with CPC in the lateral ventricle with obstructive hydrocephalus. Because of the poor demarcation between thalamus and fornix, subtotal tumor resection was performed. Postoperative spine magnetic resonance (MR) image revealed whole spinal axis dissemination. After diagnosis of CPC, the patient … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 34 publications
0
5
0
Order By: Relevance
“…Metastatic disease developed from 3 months to 8 years after these initial treatments, within one year in three patients (43%) and five years in six patients (86%) after initial treatment. 5,[7][8][9]12) Leptomeningeal spread around the spinal cord was most common in these patients. [7][8][9]11,13) Four of five patients died of progressive disease within 18 months after the salvage treatment.…”
Section: Discussionmentioning
confidence: 91%
See 3 more Smart Citations
“…Metastatic disease developed from 3 months to 8 years after these initial treatments, within one year in three patients (43%) and five years in six patients (86%) after initial treatment. 5,[7][8][9]12) Leptomeningeal spread around the spinal cord was most common in these patients. [7][8][9]11,13) Four of five patients died of progressive disease within 18 months after the salvage treatment.…”
Section: Discussionmentioning
confidence: 91%
“…5,[7][8][9]12) Leptomeningeal spread around the spinal cord was most common in these patients. [7][8][9]11,13) Four of five patients died of progressive disease within 18 months after the salvage treatment.…”
Section: Discussionmentioning
confidence: 91%
See 2 more Smart Citations
“…Although the best chemotherapy regimen for CPC is still unknown, a report revealed long-term outcomes while applying temozolomide (TMZ) in CPC patient with MGMT methylation, while another report showed no effect of TMZ in the absence of MGMT methylation [ 4 , 5 , 14 ]. In our case, TMZ-based chemotherapy did not proceed in the patient because MGMT methylation was negative in the patient.…”
Section: Discussionmentioning
confidence: 99%